USPTO serial 87083307
PHARMABIDIOL
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- LOOK, JEFFREY J
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PHARMABIDIOL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Eduardo Drake
EDUARDO DRAKE FANTASTIC IP CONSULTING1367 WILLOW ST. #3181367 WILLOW ST. SUITE 318MINNEAPOLIS, MN 55403Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for treating inflammation, nausea, convulsions, cancer, anxiety, depression; Nutraceuticals for use as a dietary supplement for treating symptoms of nicotine addiction, acne, diabetes, fibromyalgia, neurogenerative diseases, post-traumatic stress disorder; Nutraceuticals for use as a dietary supplement for treating symptoms of Crohns disease, multiple sclerosis, insomnia; Pharmaceutical agents affecting digestive organs; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Anti-epileptic pharmaceutical preparations; Dietary and nutritional supplements containing cannabis derivatives, namely, cannabidiol (CBD) oil; Dietary supplements also containing cannabis derivatives, namely, cannabidiol (CBD) oil; Digestives for pharmaceutical purposes; Medicated skin care preparations; Medicated oils containing cannabis derivatives, namely, cannabidiol (CBD) oil; Nutritional food additives for medical purposes in the nature of natural food extracts derived from cannabis, namely, cannabidiol (CBD) oil; Therapeutic pharmaceutical for the treatment of nicotine addiction, acne, diabetes, fibromyalgia, neurogenerative diseases, post-traumatic stress disorder; Therapeutic pharmaceutical for the treatment of inflammation, nausea, convulsions, cancer, anxiety, depression; Therapeutic pharmaceutical for the treatment of Crohns disease, multiple sclerosis, and insomnia | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 20, 2018 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 19, 2018 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 18, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 23, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 23, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 3, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 14, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 8, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 7, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 7, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 17, 2016 | UNDC | UNDELIVERABLE MAIL - COURTESY COPY MAILED | — |
| Oct 7, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 7, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 7, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 4, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 1, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 29, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 28, 2016 | NWAP | NEW APPLICATION ENTERED | — |